Global Bone Morphogenetic Proteins Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Bone Morphogenetic Proteins Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Bone morphogenetic proteins (BMPs) are a group of growth factors also known as cytokines and as metabologens.Originally discovered by their ability to induce the formation of bone and cartilage, BMPs are now considered to constitute a group of pivotal morphogenetic signals, orchestrating tissue architecture throughout the body.
Bone Morphogenetic Proteins report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Bone Morphogenetic Proteins market is projected to reach US$ 598.6 million in 2034, increasing from US$ 498.1 million in 2022, with the CAGR of 2.7% during the period of 2024 to 2034. Demand from Spinal Fusion and Trauma are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Bone Morphogenetic Proteins industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Bone Morphogenetic Proteins key manufacturers include Medtronic, Cellumed, Stryker, Sigma Aldrich, ProSpec, Ember therapeutics, R&D Systems and Thermo Fischer, etc. Medtronic, Cellumed, Stryker are top 3 players and held % sales share in total in 2022.
Bone Morphogenetic Proteins can be divided into rhBMP-2 and rhBMP-7, etc. rhBMP-2 is the mainstream product in the market, accounting for % sales share globally in 2022.
Bone Morphogenetic Proteins is widely used in various fields, such as Spinal Fusion, Trauma, Reconstructive Surgery and Oral-Maxillofacial, etc. Spinal Fusion provides greatest supports to the Bone Morphogenetic Proteins industry development. In 2022, global % sales of Bone Morphogenetic Proteins went into Spinal Fusion filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Bone Morphogenetic Proteins market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Medtronic
Cellumed
Stryker
Sigma Aldrich
ProSpec
Ember therapeutics
R&D Systems
Thermo Fischer
Segment by Type
rhBMP-2
rhBMP-7
Spinal Fusion
Trauma
Reconstructive Surgery
Oral-Maxillofacial
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Bone Morphogenetic Proteins market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Bone Morphogenetic Proteins, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Bone Morphogenetic Proteins industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Bone Morphogenetic Proteins in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Bone Morphogenetic Proteins introduction, etc. Bone Morphogenetic Proteins Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Bone Morphogenetic Proteins market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Bone Morphogenetic Proteins report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Bone Morphogenetic Proteins market is projected to reach US$ 598.6 million in 2034, increasing from US$ 498.1 million in 2022, with the CAGR of 2.7% during the period of 2024 to 2034. Demand from Spinal Fusion and Trauma are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Bone Morphogenetic Proteins industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Bone Morphogenetic Proteins key manufacturers include Medtronic, Cellumed, Stryker, Sigma Aldrich, ProSpec, Ember therapeutics, R&D Systems and Thermo Fischer, etc. Medtronic, Cellumed, Stryker are top 3 players and held % sales share in total in 2022.
Bone Morphogenetic Proteins can be divided into rhBMP-2 and rhBMP-7, etc. rhBMP-2 is the mainstream product in the market, accounting for % sales share globally in 2022.
Bone Morphogenetic Proteins is widely used in various fields, such as Spinal Fusion, Trauma, Reconstructive Surgery and Oral-Maxillofacial, etc. Spinal Fusion provides greatest supports to the Bone Morphogenetic Proteins industry development. In 2022, global % sales of Bone Morphogenetic Proteins went into Spinal Fusion filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Bone Morphogenetic Proteins market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Medtronic
Cellumed
Stryker
Sigma Aldrich
ProSpec
Ember therapeutics
R&D Systems
Thermo Fischer
Segment by Type
rhBMP-2
rhBMP-7
Segment by Application
Spinal Fusion
Trauma
Reconstructive Surgery
Oral-Maxillofacial
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Bone Morphogenetic Proteins market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Bone Morphogenetic Proteins, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Bone Morphogenetic Proteins industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Bone Morphogenetic Proteins in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Bone Morphogenetic Proteins introduction, etc. Bone Morphogenetic Proteins Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Bone Morphogenetic Proteins market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices